SCTV-02
重组呼吸道合胞病毒疫苗(神州细胞工程有限公司)
Report date: 2024/12/26 20:00:09
Base Information
Drug NameSCTV-02
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSinoCelltech Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A